Foghorn Therapeutics
Price & Volume
Stats
See more52W Range | $2.94-$6.95 |
Market Cap | $352.6M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $24.5M |
Revenue Growth (YoY) | 4.4% |
Gross Profit (12 Mos) | -$59.4M |
Diluted EPS | -$1.14 |
News
See moreYahoo Finance • 3 months ago
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
Yahoo Finance • 3 months ago
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
About
CEO | Mr. Adrian H. B. Gottschalk |
CFO | Mr. Jeffrey A. Sacher M.B.A. |
Address | 500 Technology Square, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 112 |
